Articles About Gilead Sciences
February 24, 2014
As the healthcare sector continues to produce awe-inspiring returns, investors may want to consider these three stocks.
February 04, 2014
Gilead has a 68 percent positive surprise history, having topped the whisper in 21 of the 31 earnings reports for which we have data.
January 28, 2014
Intercept Pharmaceuticals served as a catalyst for biotechnology firms in the fibrosis space on January 9.
January 27, 2014
Johnson & Johnson is a rare big pharma seeing long-term consistent growth unlike its peers.